1. To compare cartilage changes after KJD and after HTO, based on MRI, radiographs and biomarkers, evaluated 2 years post treatment. 2. To compare clinical efficacy after KJD and after HTO during 2 year follow-up by a questionnaire (KOOS; for pain,…
ID
Source
Brief title
Condition
- Joint disorders
- Bone and joint therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- Cartilage changes determined by decrease in area of denuded bone using
quantitative MRI analyses (according to Eckstein) at 2 years (blinded
evaluation).
Secondary outcome
- Cartilage changes determined by X-rays (joint space width using KIDA),
additional quantitative MRI parameters (Eckstein), and biochemical markers
analyses (blinded evaluation).
- Clinical efficacy over time by self assessed questionnaire (KOOS score for
pain, other symptoms, function in daily living, function in sports and
recreation, and knee related quality of life) and VAS for pain (non-blinded).
- Medical consumption and non-medical costs related to disease and treatment
are estimated by a questionnaire (custom made). Quality of life is evaluated by
questionnaires (EQ-5D) (non-blinded).
Background summary
Knee Joint Distraction (KJD) is proven to be beneficial in patients with
endstage osteoarthritis of the knee in comparison with their own baseline
profile. In the present study, KJD will be used for unicompartmental
osteoarthritis of the knee, another indication. In the study KJD will be
compared with currently used surgical techniques in treatment of
unicompartmental osteoarthritis of the knee, namely high tibial osteotomy
(HTO).
Study objective
1. To compare cartilage changes after KJD and after HTO, based on MRI,
radiographs and biomarkers, evaluated 2 years post treatment.
2. To compare clinical efficacy after KJD and after HTO during 2 year follow-up
by a questionnaire (KOOS; for pain, other symptoms, function in daily living,
function in sports and recreation, and knee related quality of life) and by a
VAS for pain.
3. To gather preliminary data on medical consumption and non-medical costs
related to disease and treatment as well as quality of life.
Study design
A multicenter (Maartenskliniek te Woerden (MK-W) and University Medical Center
Utrecht (UMC), randomised controlled, 2 years follow-up trial will be
accomplished. Patients with severe unicompartimental OA of the knee, for whom
conservative therapy fails and are indicated for a HTO by a orthopaedic surgeon
and meet the inclusion criteria will be asked to participate. After informed
consent, patients will be randomised between HTO en KJD (2:1). Structural and
clinical outcome parameters are evaluated over time up to 2 years and compared
between two treatmentstrategies. Data on direct and indirect costs as well as
change in quality of life are gathered by use of questionnaires.
Intervention
HTO is performed according to regular clinical practice. KJD is performed
according to a standard protocol. An external fixator bridging the joint by use
of two Stryker monotubes is placed. Intra-operatively the tubes are distracted
2 mm. During hospitalization the frame is further distracted, 1mm a day, until
in total 5 mm is reached. Distraction lasts for 6 weeks whereby fully load
bearing is encouraged. After 6 weeks the frame is removed at day-care surgery,
followed by sstandard care physical therapy.
Study burden and risks
All patients included will visit the outpatient clinic more frequently, namely
a total of 7 times in two years. At this visit questionnaires have to be filled
in. Additionally 10 ml of blood and 5 ml of urine will be collected, an X-ray
will be taken and 3 times a MRI examination will be performed, at baseline
(KJD+HTO), 1yr (KJD) and 2yr (KJD+HTO) evaluation. Patients treated with KJD
have the chance of developing pin-tract infections; this is a known
complication of a *fixateur externe*. These skin infections can be effectively
treated with antibiotics. Another possible disadvantage of KJD is that there is
a higher risk for knee joint contracture, aimed to prevent by adequate
physiotherapy. Rehabilitation will not be significantly different from HTO.
Heidelberglaan 100
Utrecht 3584 DW
NL
Heidelberglaan 100
Utrecht 3584 DW
NL
Listed location countries
Age
Inclusion criteria
Patients with medial or lateral tibio-femoral compartmental OA considered for HTO according to regular clinical practice,
Age < 65 years,
Radiological joint damage: Kellgren & Lawrence score 2 or higher
Intact knee ligaments
Normal range-of-motion,
normal stability
Maximum flexion limitation of 15 degrees (minimum of 120 degrees flexion pre-operative)
Body Mass Index < 35
Exclusion criteria
Mechanic axis-deviation of less than 10 degrees
Psychological inabilities or difficult to instruct
Not able to undergo MRI examination according to standard checklists Inflammatory or rheumatoid arthritis present or in history
Post traumatic fibrosis due to fracture of the tibial plateau
Bone-to-bone contact in the joint (absence of any joint space on X-ray)
Surgical treatment of the involved knee < 6 months ago
Contra-lateral knee OA that needs treatment
Primary patello-femoral osteoarthritis
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL35856.041.11 |